General

New hormone test may distinguish schizophrenia, depression

NewsGram Desk

New York, March 14, 2017: US researchers have developed a new hormone-based test that can better distinguish between the symptoms of depression and schizophrenia.

Depression is thought to affect over 300 million people worldwide and schizophrenia affects as many as 51 million people.
Clinically, it is difficult to distinguish between these two diseases in their early phases, because symptoms are non-specific and relatively mild.

NewsGram brings to you current foreign news from all over the world.

In the study, led by researchers from Yale University in Connecticut, US, the researchers infused patients with a high concentration salt solution to induce the release of the hormone arginine-vasopressin (AVP), and then measured the level of the hormone in their blood.

The results, reported in Experimental Physiology, revealed that AVP release can distinguish schizophrenia from depression.

Depressed patients showed an increased release of the hormone, while patients with schizophrenia showed a decreased response.

NewsGram brings to you top news around the world today.

Further, the novel method will help identify people whose depression or schizophrenia involves signalling via a receptor called NMDAR, and differentiate between the two diseases.

In patients with schizophrenia the NMDA receptor signalling may be decreased, while it might be high in those with depression.

This hormone test may be a simple way to distinguish and identify patients with NMDA receptor malfunction in each disorder, the researchers said.

Check out NewsGram for latest international news updates.

"This is the first objective, physiological marker for two major psychiatric disorders that, once fully developed into a clinical test, can allow for earlier and more accurate diagnosis, and selection of more appropriate medications for patients," said Handan Gunduz-Bruce from Yale University.

Distinguishing this specific form of these diseases could allow for earlier and more accurate diagnoses as well as more targeted treatment, Gunduz-Bruce added. (IANS)

NewsGram Journalism Certification Program



NewsGram invites you to join our exclusive Certification Program designed to help you excel in Journalism and Content Creation!

What You Get:

✅ Author Profile/Byline – Your own author page on NewsGram📝
✅ Certificate – Official recognition of your expertise 🎓
✅ Live Classes – Weekend sessions + One-on-one sessions on weekdays 🎥👨‍🏫
✅ Article Publication – Publish for free under expert mentorship 📰✍️
✅ Freelancing Opportunity – Potential to work with NewsGram in the future 💼🚀


📅 Limited slots available! Take the next step in your career and gain hands-on experience in digital media content writing.


Apply right now with a mail on education@newsgram.com

For more details, see the Course Guide.

As Trump Targets Chicago, Mayor Fights His 'Tyranny' With Executive Order

Pentagon Warns Microsoft: Company’s Use of China-Based Engineers Was a “Breach of Trust”

Latin American literature contains warnings for American universities that yield to Trump

Pregnant women face tough choices about medication use due to lack of safety data − here’s why medical research cuts will make it worse

Lust and Desire: The Fading Line Between What We Need and What We Want